Onco Flashcards
most common tumors first year of life
neuroblastoma nephroblastoma retinoblastoma rhabdomyosarcoma hepatoblastoma medulloblastoma
most common tumor in 2-5yrs old
embryonal tumors
leukemia
non hodgkin lymphoma
glioma
ALL risk factor
ionizing radiation
Down syndrome is associated with an estimated 10-20–fold increased risk
NF1, Bloom syndrome, ataxia-telangiectasia, and Langerhans cell histiocytosis
AML risk factor
Down syndrome and NF1
optic glioma risk factor
NF1
Hodgkin disease risk factor
ebv
burkitt lymphoma risk factor
ebv in africa
osteosarcoma risk factor
Li-Fraumeni syndrome and hereditary retinoblastoma
wilms tumor risk factor
Aniridia (WAGR)
Beckwith-Wiedemann syndrome
rhabdomyosarcoma
Li-Fraumeni syndrome and NF1
hepatoblastoma risk factor
Beckwith-Wiedemann syndrome, hemihypertrophy, Gardner syndrome, and family
history of adenomatous polyposis
leiomyosarcoma risk factor
EBV
testicular germ cell tumors risk factor
Cryptorchidism
WAGR
Wilms tumour (a tumour of the kidneys)
Aniridia (absence of the coloured part of the eye, the iris), Genitourinary anomalies
mental Retardation
mutation in the adenomatous polyposis coli (APC gene)
autosomal dominant
multiple polyps in the colon together with tumors outside the colon
The extracolonic tumors may include osteomas of the skull, thyroid cancer, epidermoid cysts, fibromas
Gardner’s syndrome or familial colorectal polyposis
autosomal dominant
numerous adenomatous polyps form mainly in the epithelium of the large intestine
start out benign, malignant transformation into colon cancer occurs when they are left untreated
Familial adenomatous polyposis FAP
blueberry muffin rash
neuroblastoma
Chromosome 11p deletion syndrome
with sporadic aniridia
Wilms tumor
Chromosome 13q deletion syndrome
Retinoblastoma, sarcoma
Trisomy 21
Lymphocytic or nonlymphocytic leukemia,
especially megakaryocytic leukemia;
transient leukemoid reaction
Klinefelter syndrome (47,XXY)
Breast cancer, extragonadal germ cell tumors
Noonan syndrome
jmml
Xeroderma pigmentosum
Basal cell and squamous cell carcinomas;
melanoma
Fanconi anemia
Leukemia, myelodysplastic syndrome, liver
neoplasias, rare head and neck tumors, GI
and GU cancers
Bloom syndrome
Leukemia, lymphoma, and solid tumors
Ataxia-telangiectasia
Lymphoma, leukemia, less commonly central
nervous system and nonneural solid tumors
Dysplastic nevus syndrome
melanoma
Wiskott-Aldrich syndrome
Lymphoma, leukemia
X-linked immunodeficiency (Duncan
syndrome
Lymphoproliferative disorder
X-linked agammaglobulinemia (Bruton
disease)
Lymphoma, leukemia
Severe combined immunodeficiency
Leukemia, lymphoma
Neurofibromatosis 1
Neurofibroma, optic glioma, acoustic
neuroma, astrocytoma, meningioma,
pheochromocytoma, sarcoma
Neurofibromatosis 2
Bilateral acoustic neuromas, meningiomas
Tuberous sclerosis
Fibroangiomatous nevi, myocardial
rhabdomyoma
Li-Fraumeni syndrome p53 gene
Bone, soft tissue sarcoma, breast
Retinoblastoma also prone to
Sarcoma
Hemihypertrophy ± Beckwith syndrome
Wilms tumor, hepatoblastoma, adrenal
carcinoma
von Hippel-Landau disease
Hemangioblastoma of the cerebellum and
retina, pheochromocytoma, renal cancer
Multiple endocrine neoplasia syndrome, type 1 (Wermer syndrome)
Parathyroid, pancreatic islet, and pituitary
tumors
Multiple endocrine neoplasia syndrome, type 2A (Sipple syndrome)
Medullary carcinoma of the thyroid,
hyperparathyroidism, pheochromocytoma
Familial adenomatous polyposis
Colorectal, thyroid carcinoma, duodenal and
periampullar carcinomas; pediatric
hepatoblastoma
Familial juvenile polyposis
Colorectal carcinoma
Hereditary nonpolyposis colon cancer
Lynch syndrome, NHPCC
Colon cancer
Gardner syndrome
Adenocarcinoma of colon, skull and soft
tissue tumors
Peutz-Jeghers syndrome
Gastrointestinal carcinoma, ovarian neoplasia
Hemochromatosis
Hepatocellular carcinoma
Glycogen storage disease 1 (von Gierke
disease)
Hepatocellular carcinoma
Tyrosinemia, galactosemia
Hepatocellular carcinoma
Diamond-Blackfan anemia
AML, myelodysplastic syndrome, osteogenic
sarcoma
Shwachman-Diamond syndrome
AML, myelodysplasia
Congenital or cyclic neutropenia
Myelodysplastic syndrome
AML
cancer with diarrhea
neuroblastoma
ganglioneuroma
release of vasoactive intestinal peptide
if ALL develops in first twin during first year of life, risk for second twin for ALL is
> 70%
if ALL develops in first twin during 5-7yrs old, risk for second twin for ALL is
2x general population
ALL diagnosis BMA
> 25% lymphoblasts
traumatic initial lumbar tap for ALL assoc with
increased risk of CNS relapse
important predictive factors in ALL tx
- age of presentation (>1yr, <10yr)
- initial leukocyte count (50, 000)
- speed of response to therapy
chromosome abnormality with high risk of relapse
t (9,22)
t (4,11)
remission definition
<5% blasts in marrow
return of neutrophil and plt to normal after 4-5weeks
effect rapid metabolizer mercaptopurine
toxicity
effect slow metabolizer mercaptopurine
treatment failure
diagnosis aml on bma
> 20% blast
FAB M3
acute promyeloblastic leukemia
t 15;17
all trans retinoic acid
imatinib is a
tyrosine kinase
elevated leukocytes with increased monocytes thrombocytopenia anemia with erythroblasts BMA myelodysplastic with <30% blasts <2yrs old noonan or neurofibromatosis 1
jmml
juvenile myelomonocytic leukemia
translocation in infantile leukemia
t 4;11
reed sternberg
hodgkin lymphoma
b symptoms
fever 39C
weight loss >10% in 3mo
night sweats
poor prognostic factors hodgkins lymphoma
tumor bulk
b symptoms
stage
oncologic emergency assoc with NHL
- superior mediastinal syndrome
- spinal cord compression
- tumor lysis
tx nhl
cyclophosphamide
vincristine
prednisone
doxorubicin
tx HL
cyclophosphamide
vincristine
procarbazine
prednisone
second most common malignancy in childhood
brain tumors
third most common malignancy in childhood
lymphoma
malignancy with highest morbidity
brain tumors
most common brain tumor 0-14yr old
pilocytic astrocytoma
and
medulloblastoma/primitive neuroectodermal tumor
brain tumor prevalence over all
supratentorial __ infratentorial
<
infrantentorial
43.2%
common brain tumor
<1yr
supratentorial
choroid plexus
teratomas
common brain tumor
1-10yr
infratentorial
pilocytic astrocytoma
medulloblastoma
common brain tumor
>10yr
supratentorial
diffuse astrocytoma
headache
nausea
vomiting
papilledema
midline brain tumor
infratentorial
equilibrium problem
gait
coordination
infratentorial brain tumor
blurred vision
diplopia
nystagmus
infratentorial brain tumor
gaze palsy
multiple cranial nerve palsies
upper motor neuron deficit
brainstem tumor
motor weakness sensory change speech change seizure reflex change
supratentorial tumor
neuroendocrine defect
suprasellar tumor
paresis of upward gaze
pupillary dilatation reactive to accomodation but not to light
nystagmus to convergence/retraction
eyelid retraction
parinaud syndrome
pineal gland tumor
preferential site for germ cell tumor
suprasellar and pineal gland
tumor with propensity to spread to csf
medulloblastoma
PNET
ependymomma
germ cell tumor
pilocytic astrocytoma usually found at
cerebellum
ct scan finding pilocytic astrocytoma
contrast enhancing nodule within the wall of a cystic mass
rosenthal fibers
pilocytic astrocytoma
microscopic finding of biphasic appearance of bundles of compact fibrillari tissue interspersed with loose spongy area
pilocytic astrocytoma
rosenthal fiber
condensed mass of glial elements in compact areas
mri of fibrillary low grade astrocytoma
lack of enhancement after contrast
Histologic characteristics
include perivascular pseudorosettes, ependymal rosettes, monomorphic
nuclear morphology, and occasional nonpalisading foci of necrosis
ependymomma
WHO grade II
poor prognostic factor for ependymomma
age (younger -> worse)
location (posterior fossa -> worse)
choroid plexus carcinoma associ with
li fraumeni
most common location of medulloblastoma
cerebellar vermis
ct or mri of medulloblastoma
solid, homogeneous,
contrast medium–enhancing mass in the posterior fossa causing
fourth ventricular obstruction and hydrocephalus
homer wright rosettes
small blue tumor
medulloblastoma
radiation medulloblastoma
24gy on craniospinal
50 to 55gy on tumor bed
solid and cystic tumor in suprasellar
craniopharyngioma
small round blue cell tumors
neuroblastoma
rhabdomyosarcoma
ewing sarcoma
non hodgkin lymphoma
neuroblastoma can develop anywhere in the ___
sympathetic NS
most common site of mets neuroblastoma
lymph node bone marrow long bones liver skin
ct scan of neuroblastoma
multiple masses with calcification and hemorrhage
test for neuroblastoma
HVA homovanillic acid
VMA vanillmandelic acid
second most common malignant ab tumor in kids
wilms
kids with horshoe kids have __ the risk of wilms
twice
prognostic factors Wilms
age
stage
tumor weight
loss of heterozygosity of chromosome 1p, 16q
wilms
<2yr
<550grams tumor
low risk
nephrectomy only
renal cell carcinoma assoc with
con hippel lindau
most common soft tissue sarcoma
rhabdomyosarcoma
most common extracranial solid tumor
neuroblastoma
vaginal rhabdomysarcoma
sarcoma botyroides
short stature skin telangiectasia small hand and feet absent thumbs osteosarcoma
rothmund thomsun syndrome
xray osteosarcoma
sunburst
differentials lytic bone lesion
osteosarcoma histiocytosis ewings lymphoma bone cyst
xray ewings
periosteal elevation
onion skinning
ewing tumor chest wall
askin tumor
most common benign bone tumor
osteochondroma
bonde dysplasi
mlutifocal benign lesion of hyaline cartilage
short stature
limb length discrepancy
ollier disease
xray osteochondroma
stalk or broad based projection
xray chondromyxoid fibroma
eccentric, lobular, metaphyseal radiolucency with sharp sclerotic scalloped margins
xray osteoid osteoma
round lucency surrounded with sclerotic bone
xray unicameral bone cyst
centrally located lesion in medullary of bone
xray aneurysmal bone cyst
lytic lesion with metaphyseal expansion surrounded by thin sclerotic rim
flexner wintersteiner rosettes
retinoblastoma
elevated B HCG
choriocarcinoma
germinoma
elevated AFP
endodermal sinus tumor or yolk sac tumor
sertoli
estrogen
leydig
androgen
mets of hepatoblastoma
lymph node
lungs
tumor marker hepatoblastoma
afp
tennis shaped bilamellar granula on electron microscope
dx?
birbeck granule
langerhans cell histiocytosis
Neurofibromatosis type 1 (autosomal dominant)
Optic pathway gliomas, astrocytoma, malignant peripheral
nerve sheath tumors, neurofibromas
Neurofibromatosis type 2 (autosomal dominant)
Vestibular schwannomas, meningiomas, spinal cord
ependymoma, spinal cord astrocytoma, hamartomas
von Hippel–Lindau (autosomal dominant)
Hemangioblastoma
Tuberous sclerosis (autosomal dominant)
Subependymal giant cell astrocytoma, cortical tubers
Li-Fraumeni (autosomal dominant)
Astrocytoma, primitive neuroectodermal tumor
Massive involvement of the liver with metastatic disease with or without respiratory distress.
Pepper syndrome
Unilateral ptosis, myosis, and anhidrosis associated with a thoracic or cervical primary tumor. Symptoms do not
resolve with tumor resection.
Horner syndrome
Limping and irritability in young child associated with bone and bone marrow metastases
Hutchinson syndrome
Myoclonic jerking and random conjugate eye movements with or without cerebellar ataxia. Often associated
with a biologically favorable and differentiated tumor. The condition is likely immune mediated, may not
resolve with tumor removal, and often exhibits progressive neuropsychologic sequelae.
Opsoclonus-myoclonus-ataxia
syndrome
Intractable secretory diarrhea due to tumor secretion of vasointestinal peptides. Tumors are generally
biologically favorable.
Kerner-Morrison syndrome
Neuroblastoma associated with other neural crest disorders, including congenital hypoventilation syndrome or
Hirschsprung disease. Germline mutations in the paired homeobox gene PHOX2B have been identified in a
subset of patients with this disease.
Neurocristopathy syndrome
diagnosis for HLH
Hemophagocytic Lymphohistiocytosis
one of the following two criteria:
- A molecular diagnosis consistent with HLH (e.g., PRF mutations,
SAP mutations)
or
- Having 5 of the following 8 signs or symptoms:
a. Fever
b. Splenomegaly
c. Cytopenia (affecting ≥2 cell lineages; hemoglobin ≤9 g/dL [or
≤10 g/dL for infants <4 wk of age], platelets <100,000/μL,
neutrophils <1,000/μL)
d. Hypertriglyceridemia (≥265 mg/dL) and/or
hypofibrinogenemia (≤150 mg/dL)
e. Hemophagocytosis in the bone marrow, spleen, or lymph
nodes without evidence of malignancy
f. Low or absent natural killer cell cytotoxicity
g. Hyperferritinemia (≥500 ng/mL)
h. Elevated soluble CD25 (interleukin-2Rα chain; ≥2,400 U/mL)